NCT01304797 2017-01-06
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
Merrimack Pharmaceuticals
Phase 1 Unknown
Merrimack Pharmaceuticals
Association Tunisienne de lutte Contre le Cancer
Medical University of Vienna